BCRX
Biocryst Pharm (BCRX)
NASDAQ
$9.69+$0.13 (+1.41%)
Price as of Aug 21, 2026 7:30 PM EDT
  • $2.4B
    Market Cap
  • 11.57%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Earnings Score

Score: 41
Valuation
BCRX
vs History
vs S&P 500
Profitability
-0
Growth
-0
Low Earnings Volatility
2

Momentum Score

Score: 65
Valuation
BCRX
vs History
vs S&P 500
3-Month Momentum
6.96%
12-Month Momentum
11.93%
3-Month Risk Adjusted Momentum
32.57%
12-Month Risk Adjusted Momentum
26.38%

True Yield

N/A
Valuation
BCRX
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
-1.14%
Net Debt Paydown Yield
-0.01%

Financial Health Score

Score: 17
Valuation
BCRX
vs History
vs S&P 500
Ohlson's O-Score
1